Viewing Study NCT00456794


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2026-06-14 @ 10:07 AM
Study NCT ID: NCT00456794
Status: COMPLETED
Last Update Posted: 2024-04-25
First Post: 2007-04-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: 12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa
Sponsor: Kyowa Kirin, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Parkinson's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Parkinson's disease View
None Levodopa View
None End of dose wearing off View
None OFF time View